NCT06651697 2026-02-17
BEFORE
University of California, San Diego
Phase 3 Recruiting
Clinical Trials
5 trialsNCT06915727 2025-10-08
An Imaging Agent (Pafolacianine) for Identifying Lesions in Pediatric Patients With Primary or Metastatic Solid Tumors
Mayo Clinic
Phase 3 Recruiting
NCT00647569 2013-09-09
VRAM
University of Aarhus
Phase 3 Completed
NCT00191646 2011-03-04
An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That Have Not Received Prior Chemotherapy
Eli Lilly and Company
Phase 3 Completed
NCT00191607 2007-01-26
A Randomized Trial for Patients With Platinum Resistant Ovarian, Fallopian or Primary Peritoneal Cancer.
Eli Lilly and Company
Phase 3 Completed